Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company's patented Veto Cell technology enables safe and selective tuning of immune responses.

Curesponse is a clinical-stage cancer diagnostics company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.

UltraSight, a joint venture of Yeda and NYU, has developed AI-based software that revolutionizes point of care diagnosis using ultrasound imaging, by eliminating the need for an expert.

Phytolon provides an ultimate solution to the global food colors issue.

Kadimastem develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as amyotrophic lateral sclerosis (ALS) and diabetes.

LifeMap Sciences develops and commercializes next-generation sequencing (NGS) analysis solutions. The company's core technology, the GeneCards Suite Knowledgebase, provides a tool to improve biomedical research and healthcare.

IDEA Bio-Medical is a commercial-stage company specializing in solutions for biological cell-imaging research, drug-discovery automation, and diagnostics.